Brief Article Open Access
Copyright ©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Sep 28, 2012; 18(36): 5101-5105
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5101
Predictive value of neutrophil infiltration as a marker of Helicobacter pylori infection
Xiao-Qing Xu, Zhen-Hua Wang, Jing-Xian Liao, Xiao-Yu Chen, Wen-Zhong Liu, Shu-Dong Xiao, Hong Lu, Department of Gastroenterology, Shanghai Renji Hospital, Shanghai Institute of Digestive Disease, Shanghai Jiaotong University School of Medicine, 145 Middle Shandong Rd, Shanghai 200001, China
Author contributions: Xu XQ performed this work and wrote the manuscript; Wang ZH and Liao JX collected patient data; Chen XY performed the histological examination; Liu WZ and Xiao SD performed the endoscopy; Lu H designed the project, directed the study and revised the draft.
Supported by The grant for Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Renji Hospital, Shanghai Jiao Tong University School of Medicine; and National Natural Science Foundation of China, No. 81170355
Correspondence to: Hong Lu, MD, PhD, Department of Gastroenterology, Shanghai Renji Hospital, Shanghai Institute of Digestive Disease, Shanghai Jiaotong University School of Medicine, 145 Middle Shandong Rd, Shanghai 200001, China. honglu02@yahoo.com
Telephone: +86-21-63200874 Fax: +86-21-63266027
Received: January 31, 2012
Revised: April 18, 2012
Accepted: May 5, 2012
Published online: September 28, 2012

Abstract

AIM: To evaluate the predictive value of neutrophil infiltration as a marker of Helicobacter pylori (H. pylori) infection.

METHODS: A total of 315 patients with dyspepsia symptoms who underwent upper gastrointestinal endoscopy were enrolled in this study. Biopsies were evaluated using the updated Sydney system. The medication history of all patients in the preceding 4 wk was recorded. The diagnosis of H. pylori infection was based on 13C-urea breath test at least 4 wk after withdrawal of antisecretory drugs, antibiotics and related drugs. For the patients with subtotal gastrectomy, the diagnosis of H. pylori infection was based on anti-H. pylori immunoglobulin G (IgG) antibody. Serum anti-H. pylori IgG antibody was measured by enzyme-linked immunosorbent assays (Biohit, Finland).

RESULTS: The sensitivity, specificity, positive predictive value and negative predictive value of neutrophil infiltration in the diagnosis of H. pylori infection were 92.3%, 83.5%, 77.4% and 94.7%, respectively. Neutrophil infiltration of gastric mucosa in the histological analysis was strongly associated with H. pylori infection (77.4% vs 5.3% in the neutrophil infiltration negative group, P = 0.000). Moderate neutrophil infiltration was more frequent in H. pylori infection when compared to mild infiltration (81.8% and 75%, respectively), but did not reach statistical significance. For those patients with negative rapid urease test, H. pylori was detected in 73.2% of patients with positive neutrophil infiltration on histology. In patients with subtotal gastrectomy, the diagnostic accuracy of neutrophil infiltration in H. pylori infection was 50%.

CONCLUSION: Neutrophil infiltration is closely associated with H. pylori and may be recognized as a sign of this infection.

Key Words: Helicobacter pylori, Histology, Neutrophil, Sensitivity, Specificity



INTRODUCTION

Detection of Helicobacter pylori (H. pylori) infection is the first and the most important step in the treatment of H. pylori-associated diseases. Urease-based tests, including the rapid urease test (RUT) and 13C/14C urea breath test (UBT), are common in the clinical practice of gastrointestinal (GI) diseases. Because of the high prevalence of H. pylori infection and high incidence of gastric cancer in China, endoscopy is recommended as the first-line management option for uninvestigated dyspepsia patients[1]. Endoscopy examination can not only diagnose pathological changes in the stomach, but the RUT based on gastric biopsy can detect H. pylori infection and has the advantages of speed and accuracy. The urea breath test as a non-invasive choice is universally accepted as the “gold standard” for the diagnosis of H. pylori infection. However, as urease-based tests, the RUT and UBT have some limitations. Many medications including acid suppressors [e.g., proton pump inhibitors (PPI), H2-receptor antagonists (H2RA)], antibiotics and bismuth influence these tests and cause false negative results[2-7]. The detection of H. pylori in histology requires experienced pathologists and special staining. It becomes very difficult in cases with a low number of organisms and in cocci-shaped organisms[5,7,8].

In patients with subtotal gastrectomy due to gastric cancer, the examination and treatment of H. pylori are the key points in preventing the recurrence of gastric cancer. The detection of H. pylori in patients after gastrectomy is difficult due to low accuracy of the UBT in this situation[9,10].

Some studies have reported that H. pylori infection is suggested by the presence of active inflammation[11,12]. Neutrophil infiltration is a hallmark of active inflammation. It is unknown whether neutrophil infiltration may be a marker of H. pylori infection. In this survey, we enrolled: (1) randomly-selected patients; (2) patients with neutrophil infiltration but negative-RUT; and (3) patients with subtotal gastrectomy and neutrophil infiltration on routine endoscopy and biopsy histology to explore the predictive value of neutrophil infiltration in the diagnosis of H. pylori infection.

MATERIALS AND METHODS
Patients

Patients presenting with upper gastrointestinal symptoms and endoscopically proven functional dyspepsia and scarred ulcer were enrolled into the study from June 2010 to September 2011 in Renji Hospital, Shanghai. Patients with active peptic ulcer and gastric cancer were excluded. A total of three biopsy specimens from the antrum or gastric remnant were taken during each endoscopy. One biopsy was used for the RUT to detect H. pylori and the other two biopsies were analyzed histologically. Informed consent was obtained from all patients in the study. Medication in the preceding 4 wk and previous H. pylori treatment before endoscopy examination were recorded.

Study design

Study 1: Patients without previous gastric surgery or antibiotic therapy, bismuth, PPI or H2RA in the preceding 4 wk were included in this study.

Study 2: Only patients with neutrophil infiltration on histological analysis, but negative RUT were candidates for entry into this study. Patients with previous gastric surgery were excluded.

Study 3: Ten subtotal gastrectomy patients with neutrophil infiltration on histological analysis were recruited into this study. Patients who had received previous H. pylori eradication therapy or antibiotic therapy, bismuth, PPI or H2RA in the preceding 4 wk were excluded.

Histology

All specimens for histological analysis were fixed in 10% formalin. An experienced pathologist analyzed the histological features of each sample using hematoxylin and eosin staining and made the diagnosis according to the updated Sydney classification[13]. The histological parameters included histological activity (neutrophil infiltration), chronic inflammation, glandular atrophy and intestinal metaplasia. Active inflammation meant the presence of neutrophil polymorphs in a background of chronic inflammation. Each category (mild, moderate, and severe) resulted in a score on a scale of 0-3 (none, 0; mild, 1; moderate, 2; severe, 3). The pathologist blinded to any clinical information counted the two specimens and calculated the average.

Assessment of H. pylori infection

13C-UBT:13C-UBTs were performed after endoscopy examination or 4 wk after withdrawal of antisecretory drugs, antibiotics and related drugs. H. pylori infection was considered positive when values were 13CO2 ≥ 4.0‰ delta over baseline.

Serological antibody test: Blood samples (5 mL venous blood) were taken from each patient prior to endoscopy. These samples were stored before analysis and then centrifuged at -20 °C. Serum anti-H. pylori immunoglobulin G (IgG) antibody was measured by enzyme-linked immunosorbent assays (Biohit, Finland) according to the manufacturer’s instructions. The IgG cut-off value which determined samples as Hp-positive was 2.5-80 ng/L.

RESULTS
Characteristics of patients included

A total of 315 patients were recruited in this study, including 261 with functional dyspepsia, 44 with scarred peptic ulcer and 10 with gastric remnant after distal gastrectomy (Table 1). Of the 10 patients with distal gastrectomy, 4 had a history of complicated peptic ulcer disease and 6 had a history of gastric cancer.

Table 1 Baseline demographic characteristics of subjects.
Study 1Study 2Study 3
No. of patients13716810
Sex (male/female)62/7566/1028/2
Age (average, range)48.8 (21-79)52.4 (21-81)55.2 (50-77)
FD/scarred ulcer123/14138/30N/A
Accuracy of neutrophil infiltration in the diagnosis of H. pylori infection

Study 1: The diagnosis of H. pylori infection was based on 13C-UBT. Sixty-two cases were positive for neutrophil infiltration, including 40 with mild and 22 with moderate infiltration. Of these 62 patients, 14 had a negative 13C-UBT and 48 had a positive 13C-UBT. Of the 40 patients with mild neutrophil infiltration, 10 had a negative 13C-UBT and 30 had a positive 13C-UBT. Of the 22 patients with moderate neutrophil infiltration, 4 had a negative 13C-UBT and 18 had a positive 13C-UBT. Seventy-five cases were negative for neutrophil infiltration. Of these patients, 71 had a negative 13C-UBT and 4 had a positive 13C-UBT (Table 2). The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of neutrophil infiltration in the diagnosis of H. pylori infection were 92.3%, 83.5%, 77.4% and 94.7%, respectively. Neutrophil infiltration was strongly associated with H. pylori infection (77.4% vs 5.3% in the neutrophil infiltration negative group, P = 0.000). Moderate neutrophil infiltration was more frequent in H. pylori infection when compared to mild infiltration (81.8% and 75%, respectively), however, this difference failed to reach statistical significance.

Table 2 Results of study 1.
Neutrophil infiltration in gastric mucosa13C- Urea breath test
PositiveNegativeTotal
Positive481462
Negative47175
Total5285137

Study 2: In 168 patients with negative RUT and positive neutrophil infiltration on histological analysis, the diagnosis of H. pylori infection was based on positive 13C-UBT. 13C-UBT is the gold standard, and H. pylori was detected in 73.2% (123/168) of patients with negative RUT and positive neutrophil infiltration on histology. 27.6% (34/123) of patients had a history of medication use (antibiotic therapy, bismuth, PPI or H2RA) in the preceding 4 wk. Of 122 patients with mild neutrophil infiltration, 87 had a positive 13C-UBT and the diagnostic accuracy was 71.3%. Of 46 patients with moderate neutrophil infiltration, 36 had a positive 13C-UBT and the diagnostic accuracy was 78.2%.

Study 3: For the patients with subtotal gastrectomy and positive neutrophil infiltration on histological analysis, the diagnosis of H. pylori infection was based on positive anti-H. pylori IgG antibody. Serum anti-H. pylori antibody is the gold standard, and H. pylori was detected in 50% (5/10) of patients including 8 with mild neutrophil infiltration and 2 with moderate neutrophil infiltration. The diagnostic accuracy was 50% (Table 3).

Table 3 Results of study 3.
No. of positive patientsAnti-HP IgG antibodyRUT13C-UBT
Mild neutrophil infiltration (n = 8)410
Moderate neutrophil infiltration (n = 2)111
DISCUSSION

The accurate diagnosis of H. pylori infection is an important step in the treatment of H. pylori-associated diseases. However, the outcome of the most commonly used urease-based H. pylori tests (RUT and UBT) may be veiled by some drugs and gastrectomy resulting in false negative results. PPIs have a marked influence on gastric pH or H. pylori density, inducing bacteria to migrate to atypical sites, thus leading to false negative UBT results as well as false negative RUT results[3,14]. Antibiotics active against H. pylori can cause a temporary decrease in the bacterial load and hinder the detection of H. pylori infection[5]. Discontinuation of antisecretory drugs and antibiotics four weeks before detection of H. pylori is currently recommended[2]. However, it is impractical for some patients suffering from severe symptoms such as acid reflux and upper GI hemorrhage to discontinue drug treatment. Gastrectomy and reconstruction make the UBT unreliable[15]. H. pylori is also difficult to detect in cases of extensive intestinal metaplasia[16]. However, detection of H. pylori infection is very important for patients with early gastric cancer, peptic ulcer and chronic atrophic gastritis.

H. pylori is found within the mucous gel layer covering the gastric mucosa. It is characterized by infiltration of inflammatory cells into the gastric mucosa which are dependent on the production of proinflammatory cytokines, especially the potent neutrophil chemotactic and activating peptide interleukin (IL)-8[17]. IL-8 is produced by gastric epithelial cells and binds to the extracellular matrix producing a chemotactic gradient that directs neutrophil migration to the epithelial surface. The density of intraepithelial neutrophils is closely related to the extent of mucosal damage and to the intensity of H. pylori infection[18-21]. Some researchers have investigated the association between the activity of inflammation and H. pylori infection and have shown that colonization of the human stomach by H. pylori can induce an inflammatory response that is characterized by dense mucosal infiltration by neutrophils[18,22,23]. According to the updated Sydney system, gastric specimens containing neutrophils indicate H. pylori-positive patients if a sufficient number of biopsies from both the antrum and corpus are taken[13]. A study by Warren et al[24] showed that neutrophils gradually disappeared after starting H. pylori treatment. Neutrophils were rapidly detected again if the treatment failed. Without treatment, the changes are life-long. However, there are no studies on the predictive value of neutrophil infiltration as a marker of H. pylori infection.

Serology testing is the preferred method for patients with bleeding ulcers and PPI consumption[8]. Fischbach et al[25] found that serum IgG, determined by ELISA, was correlated with the histological degree and the activity of gastritis. The antibody absorbance index was correlated with severe activity of gastritis in the antrum, but not with the severity of body gastritis[26]. Vorobjova et al[27] reported that seropositivity for CagA antibody was a sign of gastritis activity. In our study, we used anti-H. pylori IgG antibody as a standard to diagnose H. pylori infection in patients with subtotal gastrectomy. We found that the diagnostic accuracy was 50% for neutrophil infiltration as a marker of H. pylori infection in this situation.

Our study showed that the sensitivity, specificity, PPV and NPV of neutrophil infiltration in the diagnosis of H. pylori infection were 92.3%, 83.5%, 77.4% and 94.7%, respectively. Neutrophil infiltration was strongly associated with H. pylori infection. There was no significant difference between moderate and mild neutrophil infiltration in the diagnosis of H. pylori infection. For those with a negative RUT, H. pylori was detected in 73.2% of patients with positive neutrophil infiltration on histology.

In patients with subtotal gastrectomy due to a history of complicated peptic ulcer disease and gastric cancer, eradication of H. pylori infection can prevent ulcer relapse and metachronous gastric cancer in these patients. However, the UBT is not accurate in this situation and some patients are unable to discontinue medication. In our study, we used anti-H. pylori IgG antibody as a standard to diagnose H. pylori infection. We found that the diagnostic accuracy was 50% for neutrophil infiltration.

Detection of H. pylori infection is key step in the treatment of certain diseases. Medication and gastrectomy can result in false negative urease-based tests for H. pylori. Neutrophils are a sensitive indicator of the presence of H. pylori. In clinical practice, neutrophil infiltration in the gastric mucosa may provide the clinician with a clue for the diagnosis of H. pylori infection.

COMMENTS
Background

The accurate diagnosis of Helicobacter pylori (H. pylori) infection is the key role in the treatment of H. pylori-associated diseases. Urease-based tests, including the rapid urease test and the 13C/14C urea breath test, are common in the diagnosis of H. pylori infection. However, medications and surgery can cause false negative results in urease-based tests. Gastric mucosa with active inflammation on histology is highly suggestive of H. pylori infection and neutrophil infiltration is a hallmark of active inflammation.

Research frontiers

The predictive value of neutrophil infiltration as a marker of H. pylori infection was studied, which may provide clinicians with a clue for the diagnosis of H. pylori infection in clinical practice.

Innovations and breakthroughs

This study showed that neutrophil infiltration of gastric mucosa on histological analysis was strongly associated with H. pylori infection and suggested that neutrophil infiltration may be a sign of this infection.

Applications

The association between neutrophil infiltration and H. pylori infection, shown in the present study, may provide clinicians with a clue for the diagnosis of H. pylori infection and help them identify false negative results in urease-based tests.

Peer review

In this manuscript, the authors verified neutrophil infiltration of gastric mucosa in histology analysis was strongly associated with H. pylori infection and highlighted neutrophil infiltration can be considered as a sign of the infection, which may help the clinicians diagnose the infection of H. pylori more accurately.

Footnotes

Peer reviewer: Dr. Tamara Vorobjova, Senior Researcher in Immunology, Department of Immunology, Institute of General and Molecular Pathology, University of Tartu, Ravila, 19, 51014 Tartu, Estonia

S- Editor Lv S L- Editor Webster JR E- Editor Li JY

References
1.  Li XB, Liu WZ, Ge ZZ, Chen XY, Shi Y, Xiao SD. Helicobacter pylori "test-and-treat" strategy is not suitable for the management of patients with uninvestigated dyspepsia in Shanghai. Scand J Gastroenterol. 2005;40:1028-1031.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 15]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
2.  Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772-781.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1348]  [Cited by in F6Publishing: 1286]  [Article Influence: 75.6]  [Reference Citation Analysis (0)]
3.  Graham DY, Opekun AR, Jogi M, Yamaoka Y, Lu H, Reddy R, El-Zimaity HM. False negative urea breath tests with H2-receptor antagonists: interactions between Helicobacter pylori density and pH. Helicobacter. 2004;9:17-27.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 33]  [Cited by in F6Publishing: 32]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
4.  Bravo LE, Realpe JL, Campo C, Mera R, Correa P. Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection. Am J Gastroenterol. 1999;94:2380-2383.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in F6Publishing: 60]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
5.  Genta RM, Lash RH. Helicobacter pylori-negative gastritis: seek, yet ye shall not always find. Am J Surg Pathol. 2010;34:e25-e34.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 43]  [Cited by in F6Publishing: 32]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
6.  Oak JH, Chung WC, Jung SH, Choi KH, Kim EJ, Kang BK, Kang BR, Kong SE, Paik CN, Lee KM. [Effect of acid pump antagonist (Revaprazan, Revanex(R)) on result of 13C urea breath test in patients with Helicobacter pylori associated peptic ulcer disease]. Korean J Gastroenterol. 2011;57:8-13.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 5]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
7.  Yakoob J, Jafri W, Abid S, Jafri N, Abbas Z, Hamid S, Islam M, Anis K, Shah HA, Shaikh H. Role of rapid urease test and histopathology in the diagnosis of Helicobacter pylori infection in a developing country. BMC Gastroenterol. 2005;5:38.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 22]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
8.  Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev. 2007;20:280-322.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 476]  [Cited by in F6Publishing: 459]  [Article Influence: 27.0]  [Reference Citation Analysis (0)]
9.  Urita Y, Maeda T, Ishihara S, Sugimoto M, Watanabe T, Domon K, Miki K. Endoscopic 13C-urea breath test for detection of Helicobacter pylori infection after partial gastrectomy. Hepatogastroenterology. 2007;54:1891-1894.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Adamopoulos AB, Stergiou GS, Sakizlis GN, Tiniakos DG, Nasothimiou EG, Sioutis DK, Achimastos AD. Diagnostic value of rapid urease test and urea breath test for Helicobacter pylori detection in patients with Billroth II gastrectomy: a prospective controlled trial. Dig Liver Dis. 2009;41:4-8.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 23]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
11.  Shafii M, Nikzad SE, Kasiri H, Naghipour M. Histopathological evaluation of chronic gastritis with and without Helicobacter pylori colonization: a study from Iran. Malays J Pathol. 2008;30:27-30.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Türkay C, Erbayrak M, Bavbek N, Yenıdünya S, Eraslan E, Kasapoğlu B. Helicobacter pylori and histopathological findings in patients with dyspepsia. Turk J Gastroenterol. 2011;22:122-127.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-1181.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3221]  [Cited by in F6Publishing: 3366]  [Article Influence: 120.2]  [Reference Citation Analysis (2)]
14.  Mana F, Van Laer W, Bossuyt A, Urbain D. The early effect of proton pump inhibitor therapy on the accuracy of the 13C-urea breath test. Dig Liver Dis. 2005;37:28-32.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 9]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
15.  Tian XY, Zhu H, Zhao J, She Q, Zhang GX. Diagnostic performance of urea breath test, rapid urea test, and histology for Helicobacter pylori infection in patients with partial gastrectomy: a meta-analysis. J Clin Gastroenterol. 2012;46:285-292.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 35]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
16.  Yoo JY, Kim N, Park YS, Hwang JH, Kim JW, Jeong SH, Lee HS, Choe C, Lee DH, Jung HC. Detection rate of Helicobacter pylori against a background of atrophic gastritis and/or intestinal metaplasia. J Clin Gastroenterol. 2007;41:751-755.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 37]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
17.  Tsai HF, Hsu PN. Interplay between Helicobacter pylori and immune cells in immune pathogenesis of gastric inflammation and mucosal pathology. Cell Mol Immunol. 2010;7:255-259.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 44]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
18.  Tanko MN, Manasseh AN, Echejoh GO, Mandong BM, Malu AO, Okeke EN, Ladep N, Agaba EI. Relation between Helicobacter pylori, inflammatory (neutrophil) activity, chronic gastritis, gastric atrophy and intestinal metaplasia. Niger J Clin Pract. 2008;11:270-274.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Stolte M, Eidt S. Chronic erosions of the antral mucosa: a sequela of Helicobacter pylori-induced gastritis. Z Gastroenterol. 1992;30:846-850.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Fiocca R, Villani L, Luinetti O, Gianatti A, Perego M, Alvisi C, Turpini F, Solcia E. Helicobacter colonization and histopathological profile of chronic gastritis in patients with or without dyspepsia, mucosal erosion and peptic ulcer: a morphological approach to the study of ulcerogenesis in man. Virchows Arch A Pathol Anat Histopathol. 1992;420:489-498.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 68]  [Cited by in F6Publishing: 71]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
21.  Kalebi A, Rana F, Mwanda W, Lule G, Hale M. Histopathological profile of gastritis in adult patients seen at a referral hospital in Kenya. World J Gastroenterol. 2007;13:4117-4121.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Camorlinga-Ponce M, Aviles-Jimenez F, Cabrera L, Hernández-Pando R, Muñoz O, Soza J, Torres J. Intensity of inflammation, density of colonization and interleukin-8 response in the gastric mucosa of children infected with Helicobacter pylori. Helicobacter. 2003;8:554-560.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 18]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
23.  Moorchung N, Srivastava AN, Gupta NK, Achyut BR, Mittal B. The histopathology of chronic gastritis. Indian J Pathol Microbiol. 2007;50:18-24.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Warren JR. Gastric pathology associated with Helicobacter pylori. Gastroenterol Clin North Am. 2000;29:705-751.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 69]  [Cited by in F6Publishing: 72]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
25.  Fischbach W, Wosnik K, Kirchner T, Mössner J. Use of serum specific immunoglobulin antibodies to determine Helicobacter pylori associated gastritis. Z Gastroenterol. 1993;31:429-431.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Kreuning J, Lindeman J, Biemond I, Lamers CB. Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects. J Clin Pathol. 1994;47:227-231.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 51]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
27.  Vorobjova T, Maaroos HI, Uibo R. Immune response to Helicobacter pylori and its association with the dynamics of chronic gastritis in the antrum and corpus. APMIS. 2008;116:465-476.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 15]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]